Impaired albumin function: a novel potential indicator for liver function damage?

Abstract

Albumin is the most abundant plasma protein and albumin infusion is commonly used. Conventionally, the biologic and therapeutic effects of albumin have been thought to be due to its oncotic properties. However, albumin has a variety of biologic functions, including molecular transport, anti-oxidation, anti-inflammation, endothelial stabilisation, anti-thrombotic effects, and the adjustment of capillary permeability. Despite this, the functions of albumin have not been thoroughly investigated. Recent studies have shown non-alcoholic fatty liver disease (NAFLD), viral hepatitis, cirrhosis, and liver failure to be associated with impairments in albumin function, which are associated with impairments in liver function and disease prognosis. Post-translational modifications of albumin cause structural modifications that affect protein function. Recently, the concentration of albumin associated with normal function, the 'efficient albumin concentration', has been attracting more interest. In addition, although many biologic markers, including albumin concentration, are widely used for the assessment of early liver dysfunction in patients with liver diseases, the predictive values are unsatisfactory. However, clinical evidence has suggested that albumin function may represent a novel biomarker of early impairment in liver function. In this review, we summarise the factors affecting albumin function and discuss the clinical significance of impairments in albumin function in various liver diseases. KEY MESSAGES1. The importance of albumin depends not only on its concentration, but also on its various physiological functions. 2. Impaired albumin function has been reported in a variety of liver diseases, and is associated with disease severity and prognosis, thereby proposing the concept of 'effective albumin concentration'. 3. Albumin dysfunction occurs earlier than other conventional indicators, and albumin dysfunction may be a new biomarker of early impairment in liver function. 4. Many exogenous and endogenous factors lead to post-translational modifications of albumin, which alters the three-dimensional structure of albumin, resulting in a decrease in its biological activity.

Single Cell Gene Expression Analysis in a 3D Microtissue Liver Model Reveals Cell Type-Specific Responses to Pro-Fibrotic TGF-β1 Stimulation

“…They also retained the ability to respond to TGF-β1 (1 ng/mL) stimulation, as shown by the decrease in albumin expression and the increase in the expression of α-SMA, that correspond to hepatocellular injury and HSC activation, respectively. Both are known events that occur during liver fibrosis progression [ 29 , 30 , 31 ]. In contrast, dissociation of MTs with Accutase and Accumax led to a lower number of functional HepaRGs, as indicated by the lower number of albumin positive cells following day 3 dissociation ( Figure 3 A).…”

Relationship Between Glycosylated Hemoglobin and Short-Term Mortality of Spontaneous Intracerebral Hemorrhage

“…On the basis of other studies, it has been shown that there is a lag in the increase of liver enzymes after liver function injury. Albumin dysfunction can be adopted as a new potential indicator of liver function injury (39). (2) We should look for malabsorption problems such as eating disorders or celiac disease to improve the nutritional status.…”

Hesperidin ameliorates hepatic dysfunction and dyslipidemia in male Wistar rats exposed to cadmium chloride

“…More so, albumin is a well-known blood protein transporter and has recently been projected as a key biomarker in clinical diagnosis of early liver impairment. Its decrease in the serum has been implicated in the prognosis of chronic liver diseases such as cirrhosis of the liver, hepatitis and non-fatty acid liver disease (NAFLD) [ 51 ]. Bilirubin is an important molecule with multiple biological functions.…”